Cd20 binding molecules for the treatment of copd

Details Cd20 binding molecules for the treatment of copd Cd20 binding molecules for the treatment of copd

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 11/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2656620

Use of CD20 binding molecules, such as anti-CD20 antibodies, for the treatment of chronic obstructive pulmonary disease (COPD).

L'invention concerne l'utilisation de molécules de liaison à CD20, telles que des anticorps anti-CD20, pour le traitement de la bronchopneumopathie chronique obstructive (COPD).

Affiliated with

Also associated with

Rating

Cd20 binding molecules for the treatment of copd does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cd20 binding molecules for the treatment of copd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd20 binding molecules for the treatment of copd will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1881482